Different mechanisms by which TAZ exerts anti-tumorigenic properties (e.g., ferroptosis) or oncogenic behavior (e.g., proliferation, EMT, invasion) during RCC are also not understood. The gene discussed is WWTR1; the disease is renal cell carcinoma.